Pharmacy Times June 16, 2023
Jennifer Gershman, PharmD, CPh, PACS

Adult and maternal RSV vaccines reveal positive findings.

Respiratory syncytial virus (RSV) is a common respiratory virus that affects children and adults.1 Transmission occurs through contact with respiratory droplets from infected people and contaminated surfaces. Individuals infected with RSV may experience mild coldlike symptoms; however, serious complications (eg, bronchiolitis and pneumonia) can occur, resulting in hospitalization.2,3 Individuals infected with RSV are typically contagious for 3 to 8 days; however, infants and immunocompromised individuals may be contagious for up to 4 weeks.1 Additionally, patients can be contagious 1 to 2 days before symptoms appear. Pharmacists should emphasize that, as with COVID-19 infection, repeated RSV infections can occur.1,4

The following pediatric groups have an increased risk of experiencing severe RSV: premature infants,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Related Articles:
The risk of a bird flu pandemic is rising
Growing gulf in US life expectancy deepened by COVID-19 pandemic
Stick to the Science
Understanding the Growing Impact of Obesity in the United States
Wearable electrical nerve stimulation device eases long COVID pain and fatigue, say researchers

Share This Article